Buchumschlag

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care

Fuente: Redalyc

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Seeba Zachariah
Format:	Artículo científico
Sprache:	en
Veröffentlicht:	Centro de investigaciones y Publicaciones Farmacéuticas 2020
Schlagworte:	Medicina
Online-Zugang:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies
von: Go Shinke, et al.
Veröffentlicht: (2024)

Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
von: Ali Scrimenti
Veröffentlicht: (2019)

New anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries. A systematic review of randomized controlled trials
von: Ricardo de Alvarenga Yoshida
Veröffentlicht: (2012)

Clinical significance of recurrent venous thromboembolism
von: Nicos Labropoulos
Veröffentlicht: (2010)

Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
von: Miroslav Durila, et al.
Veröffentlicht: (2024)

Estimated impact of model‐guided venous thromboembolism prophylaxis versus real‐world practice
von: Benjamin G Mittman, et al.
Veröffentlicht: (2026)

Hospital‐associated venous thromboembolism prophylaxis use by risk assessment at a large integrated health care network in Northern California
von: James Xu, et al.
Veröffentlicht: (2024)

Safety and efficacy of anti‐coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience
von: Vilmarie Rodriguez, et al.
Veröffentlicht: (2026)

Assessment of non-cardiac surgical patients using the ACS-NSQIP calculator to predict the risk of pneumonia, cardiac complications and venous thromboembolism
von: INDHIRA PACHANO-GARCÍA
Veröffentlicht: (2021)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
von: Tyler Chanas, et al.
Veröffentlicht: (2024)

Individualización posológica de enoxaparina en un obeso extremo mediante la monitorización del factor anti-Xa
von: Arantxa Andujar Mateos
Veröffentlicht: (2016)

Clonal haemopoiesis and venous thromboembolism risk
von: David P. Steensma
Veröffentlicht: (2024)

A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism
von: Fady Allahwerdy
Veröffentlicht: (2019)

Risk factors for deep venous thrombosis in patients undergoing orthopedic surgical procedures
von: Marco Antonio González Fuenmayor
Veröffentlicht: (2022)

DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin
von: Sophie Melicine, et al.
Veröffentlicht: (2024)

New horizons in the pharmacological management of venous thromboembolism
von: Andreas Verstraete, et al.
Veröffentlicht: (2025)

Navigating venous thromboembolism risks in lung cancer patients
von: Si‐Wai Vivian Chiu, et al.
Veröffentlicht: (2024)

Peculiaridades da terapia trombolítica na síndrome nefrótica pediátrica: monitorização do fator anti-Xa
von: Patrícia Zambi Meirelles
Veröffentlicht: (2008)

Venous thromboembolism prevention protocol for adapting prophylaxis recommendations to the potential risk post total knee replacement: a randomized controlled trial
von: Mariam A. Alameri
Veröffentlicht: (2020)

Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases
von: Maren E. Buenning, et al.
Veröffentlicht: (2025)

Clinical guideline highlights for the hospitalist: Management of pediatric venous thromboembolism
von: Carly Noel, et al.
Veröffentlicht: (2026)

Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly
von: Javier Ena, et al.
Veröffentlicht: (2024)

Attention to the risk of venous thromboembolism in mechanically restrained hospitalised patients
von: Adrian Chee, et al.
Veröffentlicht: (2024)

Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
von: Sheng Li, et al.
Veröffentlicht: (2025)

Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
von: Isabel Elías
Veröffentlicht: (2016)

Association between venous thromboembolism‐associated genetic variants, coagulation factor levels, and thrombin generation potential
von: Jihee Han, et al.
Veröffentlicht: (2024)

Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
von: Qian Li, et al.
Veröffentlicht: (2024)

Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay
von: Renata Jurema Medeiros
Veröffentlicht: (2023)

The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials
von: Loay A. Salman, et al.
Veröffentlicht: (2024)

Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty
von: Nameer van Oosterom, et al.
Veröffentlicht: (2024)

Pulmonary thromboembolism in an anticoagulated oncological patient
von: Diana Alegre-González
Veröffentlicht: (2023)

Three cases of neutralization of factor Xa inhibitors with andexanet alfa under rotational thromboelastography monitoring
von: Takeshi Yagi, et al.
Veröffentlicht: (2024)

Comparison of four D ‐dimer assays in the context of venous thromboembolism in the emergency department
von: Fabio Del Ben, et al.
Veröffentlicht: (2024)

Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
von: Lara N. Roberts, et al.
Veröffentlicht: (2024)

Symptomatic and asymptomatic venous thromboembolism after minimally invasive surgery for gynecological cancers
von: Michiko Kubo‐Kaneda, et al.
Veröffentlicht: (2025)

Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review
von: Kevin Rajon
Veröffentlicht: (2017)

Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC‐MS and anti‐Xa assay?
von: Henriette Røed‐Undlien, et al.
Veröffentlicht: (2024)

Current surgical management of chronic thromboembolic pulmonary disease
von: Hayley Barnes, et al.
Veröffentlicht: (2024)

Synchronous eyelid oncocytoma and conjunctival intraepithelial neoplasia
von: Zachariah Chowdhury
Veröffentlicht: (2021)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
von: Giorgia Lodetti
Veröffentlicht: (2023)